Moderna WeCare Team

CONTACT

Lead Sponsor

ModernaTX, Inc.

Age

18 - 30 years

Sex

ALL

Healthy Volunteers

Yes

•Healthy as determined by medical evaluation including medical history and physical examination.
•Participants who are assigned female at birth or could become pregnant are eligible to participate if the participant is not pregnant or breast/chest feeding.

•Have undergone surgical procedures within 7 days prior to Day 1 or Day 57 or are scheduled to undergo a surgical procedure within 28 days after study intervention administration.
•Reported history of congenital or acquired immunodeficiency, immunosuppressive condition, asplenia, or recurrent severe infectious disease.
•Received corticosteroids at ≥10 milligrams per day (mg/day) of prednisone or equivalent for \>14 days in total within 90 days prior to Day 1 or is anticipating the need for corticosteroids at any time during the study.
•Received systemic immunosuppressive treatment, including long-acting biological therapies that affect immune responses, within 180 days prior to Day 1 or plans to do so during the study.
•Received or plans to receive any nonstudy vaccine from 28 days prior to first dose/Day 1 up to 28 days after the second dose/Day 57.
•History of myocarditis, pericarditis, or myopericarditis prior to Day 1.
•Has previously received an investigational EBV vaccine.